Mazor Robotics' Renaissance robot-assisted surgical system treats its 1st Parkinson's patient with a deep-brain stimulation implant.
MASSDEVICE ON CALL — For the 1st time Mazor Robotics' (PINK:MZRTF) Renaissance robot-assisted surgical system system was used to to treat a Parkinson's patient, implanting a battery-sized neurostimulator that delivers mild electrical stimulation to targeted areas of the brain.
The landmark procedure took place at a Florida hospital earlier this month. Caesarea, Israel-based Mazor said 2 more patients have since been treated with positive results.
Deep-brain stimulation has been used to treat the symptoms of Parkinson's disease in approximately 30,000 people worldwide, according to a company statement. The device maker is planning a wider 2014 commercial launch of its surgical system for use in brain procedures.
Mazor's Renaissance robot system has been cleared in the U.S. for brain surgery, but had never before been used in a deep-brain stimulation procedure to treat Parkinson's disease. More than 35 patients in Germany alone have successfully undergone brain biopsy procedures using the Mazor robot.
The FDA labels as Class I CareFusion's recall of its Avea ventilators over a possibly fatal...
Small medtech companies are finding value in outsourcing their research & development functions,...
VertiFlex says it won pre-market approval from the FDA for its Superion interspinous spacer.
China is investigating a former top healthcare official on suspicion of bribery.
Medtronic is reportedly looking to grow its presence in China with lower-cost devices, as well as...